Sichuan Nuodikang Weiguang Pharmaceutical

Sichuan Nuodikang Weiguang Pharmaceutical is a specialized pharmaceutical manufacturer based in Chengdu, China, and serves as a primary production subsidiary for Tibet Rhodiola Pharmaceutical Holding Co., Ltd. The company is most recognized for its production of XinHuo (Recombinant Human B-type Natriuretic Peptide), a critical biologic therapy for the treatment of acute heart failure. Beyond its flagship biologic, the firm manufactures a variety of chemical drugs and traditional Chinese medicine products focused on cardiovascular and systemic health. Its facilities are GMP-certified, supporting both large-scale commercial production and clinical-stage manufacturing. As a key asset within the Tibet Pharmaceutical group, it contributes significantly to the parent company's revenue and market presence in the cardiovascular sector.